Transfusing platelets 2 h after the completion of amphotericin-B decreases its detrimental effect on transfused platelet recovery and survival

Transfusion Medicine

Volumn 8, Issue 1, 1998, Pages 43-47

  Hussein, M A ^a   Fletcher, R ^b   Long, T J ^c   Zuccaro, K ^a   Bolwell, B J ^a   Hoeltge, G A ^c  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b Washington State   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Amphotericin B; Platelet recovery; Platelet survival; Platelet transfusion

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT;

ARTICLE; BLOOD; BONE MARROW TRANSPLANTATION; CELL SURVIVAL; DRUG ADMINISTRATION; DRUG EFFECT; GRAFT SURVIVAL; HUMAN; IMMUNE DEFICIENCY; METHODOLOGY; MYCOSIS; NEOPLASM; RETROSPECTIVE STUDY; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TIME;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; BLOOD PLATELETS; BONE MARROW TRANSPLANTATION; CELL SURVIVAL; DRUG ADMINISTRATION SCHEDULE; GRAFT SURVIVAL; HUMANS; IMMUNOCOMPROMISED HOST; MYCOSES; NEOPLASMS; PLATELET COUNT; PLATELET TRANSFUSION; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA; TIME FACTORS;

EID: 0032032640     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3148.1998.00124.x     Document Type: Article

References (12)

1. Bishop, J.F., McGrath, K., Wolf, M.M. et al. (1988) Clinical factors influencing the efficacy of pooled platelet transfusions. Blood, 71, 383-387.
2. Daly, P., Schiffer, C., Aisner, J. & Wiernik, P. (1980) Platelet transfusion therapy. Journal of the American Medical Association, 28, 435-438.
3. Greenberg, J., Packham, M.A., Cazenave, J.P., Reimers, H.J. & Mustard, J.F. (1975) Effects on platelet function of removal of platelet sialic acid by neuraminidase. Laboratory Investigations, 32, 476-484.
4. Heyman, M.R. & Schiffer, C.A. (1990) Platelet transfusion therapy for cancer patients. Seminars in Oncology, 17, 198-209.
5. Hussein, M.A. & Hoeltge, G.A. (1996) Platelet transfusion therapy for medical and surgical patients. Cleveland Clinical Journal of Medicine, 63, 245-250.
6. Hussein, M.A., Lee, E.J. & Schiffer, C.A. (1990) Platelet transfusions administered to patients with splenomegaly. Transfusion, 30, 508-510.
7. Hussein, M.A., Long, T. & Zuccaro, K. (1995) Platelet transfusion recovery and survival in bone marrow transplant patients. A prospective study. Blood, 86, 103a.
8. Kulpa, J., Zaroulis, C.G., Good, R.A. & Kutti, J. (1981) Altered platelet function and circulation induced by amphotericin B in leukemic patients after platelet transfusion. Transfusion, 21, 74-76.
9. Norol, F., Kuentz, M., Cordonnier, C. et al (1994) Influence of clinical status on the efficacy of stored platelet transfusion. British Journal of Haematology, 86, 125-129.
10. O'Connell, B., Lee, E.J. & Schiffer, C.A. (1988) The value of 10 minute post-transfusion platelet counts. Transfusion, 28, 66-67.
11. Sloand, E.M., Kumar, P., Yu, M. & Klein, H.G. (1994) Effect of amphotericin B. and fluconazole on platelet membrane glycoproteins. Transfusion, 34, 415-420.
12. Terrell, C.L. & Hughes, C.E. (1992) Antifungal agents used for deep-seated mycotic infections. Mayo Clinic Proceedings, 67, 69-91.